CTVA:NYSECorteva, Inc. analysis

Corteva is trading at $78.28, just above the calculated support of $78.13 and below its 20‑day ($80.90) and 50‑day ($81.26) moving averages, suggesting limited upside in the immediate term. The bearish MACD histogram and a decreasing volume trend reinforce a neutral‑to‑slightly bearish short‑term bias, while the RSI of 41 indicates the stock is not yet oversold. On the valuation side, the DCF‑derived fair value of $78.96 places the market price within a modest discount, translating to an upside of roughly 15% when measured against the analyst median target of $90.
Fundamentally, CTVA delivers solid top‑line growth of 11% YoY, robust gross (48.6%) and operating (23.7%) margins, and a low debt‑to‑equity ratio of 13.6%, supporting a sustainable dividend yield of 0.92% with a 38% payout ratio. The forward PE of 19.1 contrasts sharply with the trailing PE of 42.3, indicating earnings acceleration, while the low beta (~0.3) and a high 30‑day volatility of 24% suggest limited market correlation but notable price swings. Analyst consensus remains a “Buy” with a mean target near $90, aligning with the upside potential from both DCF and consensus estimates.